Bone marrow–derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway-Reference-Cited by-同舟云学术

Bone marrow–derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway

Published:2019-08 Issue:32 Volume:294 Page:12167-12179
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhang Xiaoyan,Tu Huaijun,Yang Yazhi,Jiang Xiaoyan,Hu Xianliang,Luo Qidong,Li Jian

Funder

Major Basic Research Projects of Jiangxi Province

National Natural Science Foundation of China (NSF)

Graduate Student Innovation Fund of Jiangxi Province

Jiangxi Provincial Health and Family Planning Commission Science and Technology Program

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference49 articles.

1. Chronic myeloid leukemia;Sawyers;N. Engl. J. Med,1999

2. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene;Ben-Neriah;Science,1986

3. Chromosome studies on normal and leukemic human leukocytes;Nowell;J. Natl. Cancer Inst,1960

4. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N. Engl. J. Med,2003

5. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N. Engl. J. Med,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs;Genes;2024-06-02

2. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs;Cellular Signalling;2024-04

3. Advances in IL-7 Research on Tumour Therapy;Pharmaceuticals;2024-03-25

4. Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia;International Journal of Molecular Sciences;2024-02-21

5. Mesenchymal stromal cells in myeloid malignancies: Immunotherapeutic opportunities;Heliyon;2024-02